Making it or breaking it: DNA methylation and genome integrity
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Cells encounter a multitude of external and internal stress-causing agents that can ultimately lead to DNA damage, mutations and disease. A cascade of signaling events counters these challenges to DNA, which is termed as the DNA damage response (DDR). The DDR preserves genome integrity by engaging appropriate repair pathways, while also coordinating cell cycle and/or apoptotic responses. Although many of the protein components in the DDR are identified, how chemical modifications to DNA impact the DDR is poorly understood. This review focuses on our current understanding of DNA methylation in maintaining genome integrity in mammalian cells. DNA methylation is a reversible epigenetic mark, which has been implicated in DNA damage signaling, repair and replication. Sites of DNA methylation can trigger mutations, which are drivers of human diseases including cancer. Indeed, alterations in DNA methylation are associated with increased susceptibility to tumorigenesis but whether this occurs through effects on the DDR, transcriptional responses or both is not entirely clear. Here, we also highlight epigenetic drugs currently in use as therapeutics that target DNA methylation pathways and discuss their effects in the context of the DDR. Finally, we pose unanswered questions regarding the interplay between DNA methylation, transcription and the DDR, positing the potential coordinated efforts of these pathways in genome integrity. While the impact of DNA methylation on gene regulation is widely understood, how this modification contributes to genome instability and mutations, either directly or indirectly, and the potential therapeutic opportunities in targeting DNA methylation pathways in cancer remain active areas of investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations at these methylation sites could impair these regulatory functions, thereby affecting TP53’s capacity to suppress tumor development [28].”
From The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies (2025) · cites this paper as [28]
In the citing paper
“Methylation, particularly of arginine residues, plays a role in controlling TP53’s stability, interactions, and activity as a tumor suppressor.”
From The impact of mutations on TP53 protein and MicroRNA expression in HNSCC: Novel insights for diagnostic and therapeutic strategies (2025) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 1×
“While promoter methylation is generally associated with transcriptional gene silencing, gene body hypermethylation correlates with gene activation [7].”
BackgroundTet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Causes and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079 · cited 1×
“Repair mechanisms are usually initiated to allow the fork to continue, but this event can also result in ‘fork collapse’, which ultimately leads to the formation of DSBs that trigger the DDR [57].”
BackgroundMechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039
DNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · cited 1×
“This leads to a CGI methylator phenotype (CIMP) that remodels the methylome and transcriptome due to inactivation of TET-mediated demethylation pathway [80].”
BackgroundPCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Endogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Impact of cytosine methylation on DNA binding specificities of human transcription factors
Yin, Y., Morgunova, E., Jolma, A., Kaasinen, E., Sahu, B., Khund-Sayeed, S., Das, P. K., Kivioja, T., Dave, K., Zhong, F., et al. (2017) · Science · doi:10.1126/science.aaj2239 · Cited by 1,257 · cited 1×
“Structural analysis has indicated that transcription factors containing bZIP and homeodomain bind methylated CpG sequences in vitro [27,28].”
BackgroundPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233 · cited 1×
“In the case of BRCA1, methylation of CpG sites close to the transcriptional start site (TSS) is associated with reduced mRNA and protein levels [83].”
Background
Research works printed but not linked: 103
- Jackson, 2009, The DNA-damage response in human biology and disease, Nature, 461, 1071, 10.1038/nature08467 · DOI · Paper page
- Puget, 2019, Non-canonical DNA/RNA structures during transcription-coupled double-strand break repair: roadblocks or bona fide repair intermediates?, DNA Repair (Amst.), 81, 102661, 10.1016/j.dnarep.2019.102661 · DOI · Paper page
- Kim, 2019, Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity, Genes Dev., 33, 1751, 10.1101/gad.331231.119 · DOI
- Jeggo, 2016, DNA repair, genome stability and cancer: a historical perspective, Nat. Rev. Cancer, 16, 35, 10.1038/nrc.2015.4 · DOI · Paper page
- Goto, 1998, Regulation of X-chromosome inactivation in development in mice and humans, Microbiol. Mol. Biol. Rev., 62, 362, 10.1128/MMBR.62.2.362-378.1998 · DOI · Paper page
- Hermann, 2004, The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites, J. Biol. Chem., 279, 48350, 10.1074/jbc.M403427200 · DOI · Paper page
- Bostick, 2007, UHRF1 plays a role in maintaining DNA methylation in mammalian cells, Science, 317, 1760, 10.1126/science.1147939 · DOI · Paper page
- Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6 · DOI · Paper page
- Hata, 2002, Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice, Development, 129, 1983, 10.1242/dev.129.8.1983 · DOI · Paper page
- Bourc’his, 2001, Dnmt3L and the establishment of maternal genomic imprints, Science, 294, 2536, 10.1126/science.1065848 · DOI · Paper page
- Goll, 2006, Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2, Science, 311, 395, 10.1126/science.1120976 · DOI · Paper page
- Xhemalce, 2013, From histones to RNA: role of methylation in cancer, Brief. Funct. Genomics, 12, 244, 10.1093/bfgp/els064 · DOI
- Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 · DOI · Paper page
- Iyer, 2009, Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids, Cell Cycle, 8, 1698, 10.4161/cc.8.11.8580 · DOI · Paper page
- He, 2011, Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA, Science, 333, 1303, 10.1126/science.1210944 · DOI · Paper page
- Maiti, 2011, Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites, J. Biol. Chem., 286, 35334, 10.1074/jbc.C111.284620 · DOI · Paper page
- Li, 2015, Gadd45a promotes DNA demethylation through TDG, Nucleic Acids Res., 43, 3986, 10.1093/nar/gkv283 · DOI
- Rai, 2008, DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45, Cell, 135, 1201, 10.1016/j.cell.2008.11.042 · DOI · Paper page
- Wu, 2010, Active DNA demethylation: many roads lead to Rome, Nat. Rev. Mol. Cell Biol., 11, 607, 10.1038/nrm2950 · DOI · Paper page
- Kagiwada, 2013, Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice, EMBO J., 32, 340, 10.1038/emboj.2012.331 · DOI · Paper page
- Hudson, 2018, Zinc finger readers of methylated DNA, Molecules, 23, 10.3390/molecules23102555 · DOI
- Vilas, 2018, Caught with one’s zinc fingers in the genome integrity cookie jar, Trends Genet., 34, 313, 10.1016/j.tig.2017.12.011 · DOI
- Hong, 2017, Methyl-dependent and spatial-specific DNA recognition by the orthologous transcription factors human AP-1 and Epstein-Barr virus Zta, Nucleic Acids Res., 45, 2503, 10.1093/nar/gkx057 · DOI
- Ginder, 2018, Readers of DNA methylation, the MBD family as potential therapeutic targets, Pharmacol. Ther., 184, 98, 10.1016/j.pharmthera.2017.11.002 · DOI
- Mahmood, 2019, DNA methylation readers and cancer: mechanistic and therapeutic applications, Front. Oncol., 9, 489, 10.3389/fonc.2019.00489 · DOI
- Stirzaker, 2017, Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer, Oncogene, 36, 1328, 10.1038/onc.2016.297 · DOI
- Hendrich, 1998, Identification and characterization of a family of mammalian methyl-CpG binding proteins, Mol. Cell. Biol., 18, 6538, 10.1128/MCB.18.11.6538 · DOI · Paper page
- Leighton, 2019, The Methyl-CpG-binding domain 2 and 3 proteins and formation of the nucleosome remodeling and deacetylase complex, J. Mol. Biol., 432, 1624, 10.1016/j.jmb.2019.10.007 · DOI
- Hendrich, 1999, The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites, Nature, 401, 301, 10.1038/45843 · DOI · Paper page
- Kimura, 2003, Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1, J. Biol. Chem., 278, 4806, 10.1074/jbc.M209923200 · DOI · Paper page
- Sharif, 2007, The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA, Nature, 450, 908, 10.1038/nature06397 · DOI · Paper page
- Zhou, 2014, Structural basis for hydroxymethylcytosine recognition by the SRA domain of UHRF2, Mol. Cell, 54, 879, 10.1016/j.molcel.2014.04.003 · DOI
- Filion, 2006, A family of human zinc finger proteins that bind methylated DNA and repress transcription, Mol. Cell. Biol., 26, 169, 10.1128/MCB.26.1.169-181.2006 · DOI · Paper page
- Hodges, 2019, Cys2His2 zinc finger methyl-CpG binding proteins: getting a handle on methylated DNA, J. Mol. Biol., 432, 1640, 10.1016/j.jmb.2019.09.012 · DOI
- Lang, 2017, CTCF prevents genomic instability by promoting homologous recombination-directed DNA double-strand break repair, Proc. Natl. Acad. Sci. U.S.A., 114, 10912, 10.1073/pnas.1704076114 · DOI · Paper page
- Hilmi, 2017, CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair, Sci. Adv., 3, e1601898, 10.1126/sciadv.1601898 · DOI
- Woodcock, 2019, Human MettL3-MettL14 complex is a sequence-specific DNA adenine methyltransferase active on single-strand and unpaired DNA in vitro, Cell Discov., 5, 63, 10.1038/s41421-019-0136-4 · DOI
- Hao, 2020, N(6)-Deoxyadenosine methylation in mammalian mitochondrial DNA, Mol. Cell, 78, 382, 10.1016/j.molcel.2020.02.018 · DOI · Paper page
- Xiong, 2019, N(6)-Hydroxymethyladenine: a hydroxylation derivative of N6-methyladenine in genomic DNA of mammals, Nucleic Acids Res., 47, 1268, 10.1093/nar/gky1218 · DOI
- Greenblatt, 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855
- Sassa, 2016, Mutagenic consequences of cytosine alterations site-specifically embedded in the human genome, Genes Environ., 38, 17, 10.1186/s41021-016-0045-9 · DOI
- Tommasi, 1997, Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases, Cancer Res., 57, 4727
- Deniz, 2019, Regulation of transposable elements by DNA modifications, Nat. Rev. Genet., 20, 417, 10.1038/s41576-019-0117-3 · DOI
- Rodic, 2014, Long interspersed element-1 protein expression is a hallmark of many human cancers, Am. J. Pathol., 184, 1280, 10.1016/j.ajpath.2014.01.007 · DOI · Paper page
- Chuang, 1997, Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1, Science, 277, 1996, 10.1126/science.277.5334.1996 · DOI · Paper page
- Pradhan, 2002, The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity, EMBO J., 21, 779, 10.1093/emboj/21.4.779 · DOI
- Xia, 2019, Bacteria-to-human protein networks reveal origins of endogenous DNA damage, Cell, 176, 127.e24, 10.1016/j.cell.2018.12.008 · DOI
- Ren, 2020, Direct readout of heterochromatic H3K9me3 regulates DNMT1-mediated maintenance DNA methylation, Proc. Natl. Acad. Sci. U.S.A., 117, 18439, 10.1073/pnas.2009316117 · DOI · Paper page
- Jones, 1997, Altered DNA methylation and genome instability: a new pathway to cancer?, Proc. Natl. Acad. Sci. U.S.A., 94, 2103, 10.1073/pnas.94.6.2103 · DOI · Paper page
- Chen, 2007, Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells, Nat. Genet., 39, 391, 10.1038/ng1982 · DOI · Paper page
- Okano, 2002, Genetic analyses of DNA methyltransferase genes in mouse model system, J. Nutr., 132, 2462S, 10.1093/jn/132.8.2462S · DOI
- Ha, 2011, Rapid and transient recruitment of DNMT1 to DNA double-strand breaks is mediated by its interaction with multiple components of the DNA damage response machinery, Hum. Mol. Genet., 20, 126, 10.1093/hmg/ddq451 · DOI · Paper page
- Lee, 2010, DNA methyltransferase 1-associated protein (DMAP1) is a co-repressor that stimulates DNA methylation globally and locally at sites of double strand break repair, J. Biol. Chem., 285, 37630, 10.1074/jbc.M110.148536 · DOI · Paper page
- Georgia, 2013, DNMT1 represses p53 to maintain progenitor cell survival during pancreatic organogenesis, Genes Dev., 27, 372, 10.1101/gad.207001.112 · DOI
- Loughery, 2011, DNMT1 deficiency triggers mismatch repair defects in human cells through depletion of repair protein levels in a process involving the DNA damage response, Hum. Mol. Genet., 20, 3241, 10.1093/hmg/ddr236 · DOI · Paper page
- Xia, 2017, CHD4 has oncogenic functions in initiating and maintaining epigenetic suppression of multiple tumor suppressor genes, Cancer Cell, 31, 653.e7, 10.1016/j.ccell.2017.04.005 · DOI · Paper page
- Cuozzo, 2007, DNA damage, homology-directed repair, and DNA methylation, PLoS Genet., 3, e110, 10.1371/journal.pgen.0030110 · DOI · Paper page
- Kafer, 2016, 5-Hydroxymethylcytosine marks sites of DNA damage and promotes genome stability, Cell Rep., 14, 1283, 10.1016/j.celrep.2016.01.035 · DOI · Paper page
- Jiang, 2017, TET3-mediated DNA oxidation promotes ATR-dependent DNA damage response, EMBO Rep., 18, 781, 10.15252/embr.201643179 · DOI
- Jiang, 2015, Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency, Brain, 138, 3520, 10.1093/brain/awv284 · DOI · Paper page
- Lahtz, 2011, Epigenetic changes of DNA repair genes in cancer, J. Mol. Cell Biol., 3, 51, 10.1093/jmcb/mjq053 · DOI · Paper page
- Kang, 2001, Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma, Lab. Invest., 81, 573, 10.1038/labinvest.3780266 · DOI
- Chmelarova, 2013, Methylation in the p53 promoter in epithelial ovarian cancer, Clin. Transl. Oncol., 15, 160, 10.1007/s12094-012-0894-z · doi:10.1007/s12094-012-0894-z
- Jin, 2013, DNA methyltransferases, DNA damage repair, and cancer, Adv. Exp. Med. Biol., 754, 3, 10.1007/978-1-4419-9967-2_1 · DOI · Paper page
- Yan, 2011, Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia, Nat. Genet., 43, 309, 10.1038/ng.788 · DOI · Paper page
- Roller, 2013, Landmark analysis of DNMT3A mutations in hematological malignancies, Leukemia, 27, 1573, 10.1038/leu.2013.65 · DOI
- Shah, 2011, DNMT3A mutations in acute myeloid leukemia, Nat. Genet., 43, 289, 10.1038/ng0411-289 · DOI
- Park, 2020, Characteristics of DNMT3A mutations in acute myeloid leukemia, Blood Res., 55, 17, 10.5045/br.2020.55.1.17 · DOI
- Ferreira, 2016, DNMT3A mutations mediate the epigenetic reactivation of the leukemogenic factor MEIS1 in acute myeloid leukemia, Oncogene, 35, 3079, 10.1038/onc.2015.359 · DOI
- Kohlmann, 2005, New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes, Leukemia, 19, 953, 10.1038/sj.leu.2403746 · DOI
- Langemeijer, 2009, Acquired mutations in TET2 are common in myelodysplastic syndromes, Nat. Genet., 41, 838, 10.1038/ng.391 · DOI · Paper page
- Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 · DOI · Paper page
- Cimmino, 2015, TET1 is a tumor suppressor of hematopoietic malignancy, Nat. Immunol., 16, 653, 10.1038/ni.3148 · DOI · Paper page
- Huang, 2013, TET1 plays an essential oncogenic role in MLL-rearranged leukemia, Proc. Natl. Acad. Sci. U.S.A., 110, 11994, 10.1073/pnas.1310656110 · DOI · Paper page
- Subramaniam, 2014, DNA methyltransferases: a novel target for prevention and therapy, Front. Oncol., 4, 80, 10.3389/fonc.2014.00080 · DOI · Paper page
- Ganesan, 2019, The timeline of epigenetic drug discovery: from reality to dreams, Clin. Epigenet., 11, 174, 10.1186/s13148-019-0776-0 · DOI · Paper page
- Christman, 2002, 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy, Oncogene, 21, 5483, 10.1038/sj.onc.1205699 · DOI · Paper page
- Santi, 1984, Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine, Proc. Natl. Acad. Sci. U.S.A., 81, 6993, 10.1073/pnas.81.22.6993 · DOI · Paper page
- Palii, 2008, DNA methylation inhibitor 5-Aza-2′-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B, Mol. Cell. Biol., 28, 752, 10.1128/MCB.01799-07 · DOI · Paper page
- Orta, 2013, 5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair, Nucleic Acids Res., 41, 5827, 10.1093/nar/gkt270 · DOI
- Zambrano, 2005, A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes, BMC Cancer, 5, 44, 10.1186/1471-2407-5-44 · DOI
- Cheng, 2003, Inhibition of DNA methylation and reactivation of silenced genes by zebularine, J. Natl. Cancer Inst., 95, 399, 10.1093/jnci/95.5.399 · DOI · Paper page
- Cheng, 2004, Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells, Mol. Cell. Biol., 24, 1270, 10.1128/MCB.24.3.1270-1278.2004 · DOI · Paper page
- Johnson, 2006, A pharmacokinetic/pharmacodynamic approach to evaluating the safety of zebularine in non-human primates, Cancer Res., 66, 309
- Zacharioudakis, 2017, Chromatin regulates genome targeting with cisplatin, Angew. Chem. Int. Ed. Engl., 56, 6483, 10.1002/anie.201701144 · DOI
- Pohlmann, 2002, Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix, Am. J. Clin. Oncol., 25, 496, 10.1097/00000421-200210000-00015 · DOI
- Viet, 2014, Decitabine rescues cisplatin resistance in head and neck squamous cell carcinoma, PLoS ONE, 9, e112880, 10.1371/journal.pone.0112880 · DOI
- Khandelwal, 2018, Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A, Mol. Cell. Biochem., 446, 105, 10.1007/s11010-018-3278-z · DOI
- Benson, 2015, Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study, PLoS ONE, 10, e0141279, 10.1371/journal.pone.0141279 · DOI
- Muvarak, 2016, Enhancing the cytotoxic effects of PARP inhibitors with DNA demethylating agents - a potential therapy for cancer, Cancer Cell, 30, 637, 10.1016/j.ccell.2016.09.002 · DOI · Paper page
- Caron, 2019, Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks, Nat. Commun., 10, 2954, 10.1038/s41467-019-10741-9 · DOI · Paper page
- Luijsterburg, 2016, PARP1 links CHD2-mediated chromatin expansion and H3.3 deposition to DNA repair by non-homologous end-joining, Mol. Cell, 61, 547, 10.1016/j.molcel.2016.01.019 · DOI · Paper page
- Giri, 2019, DNMT inhibitors increase methylation in the cancer genome, Front. Pharmacol., 10, 10.3389/fphar.2019.00385 · DOI
- Ding, 2016, Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage, J. Mol. Cell Biol., 8, 244, 10.1093/jmcb/mjv050 · DOI · Paper page
- Gong, 2017, Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair, J. Cell Biol., 216, 1959, 10.1083/jcb.201611135 · DOI · Paper page
- Bernstein, 2015, Epigenetic reduction of DNA repair in progression to gastrointestinal cancer, World. J. Gastrointest. Oncol., 7, 30, 10.4251/wjgo.v7.i5.30 · DOI
- Tessitore, 2014, MicroRNAs in the DNA damage/repair network and cancer, Int. J. Genomics, 2014, 820248, 10.1155/2014/820248 · DOI
- Juhasz, 2018, ATRX promotes DNA repair synthesis and sister chromatid exchange during homologous recombination, Mol. Cell, 71, 11.e7, 10.1016/j.molcel.2018.05.014 · DOI
- Hsieh, 2017, The Devil is in the details for DNA mismatch repair, Proc. Natl. Acad. Sci. U.S.A., 114, 3552, 10.1073/pnas.1702747114 · DOI
- Arab, 2019, GADD45A binds R-loops and recruits TET1 to CpG island promoters, Nat. Genet., 51, 217, 10.1038/s41588-018-0306-6 · DOI · Paper page
- Hansel-Hertsch, 2017, DNA G-quadruplexes in the human genome: detection, functions and therapeutic potential, Nat. Rev. Mol. Cell Biol., 18, 279, 10.1038/nrm.2017.3 · DOI · Paper page
- Mao, 2018, DNA G-quadruplex structures mold the DNA methylome, Nat. Struct. Mol. Biol., 25, 951, 10.1038/s41594-018-0131-8 · DOI · Paper page
- Joyce, 2018, DNA methylation of telomere-related genes and cancer risk, Cancer Prev. Res., 11, 511, 10.1158/1940-6207.CAPR-17-0413 · DOI
Cited by
Mahmoud, A. A., Raih, M. F., Sage, E. E., Ali, Q. M., Suliman, O. H., Ibrahim, S. A. E., Mohamed, O., Abdelrazeg, S., & Mohamed, S. B. (2025) · PLOS One · doi:10.1371/journal.pone.0307859 · Cited by 4
Metadata
- Authors
- Sriraman, A., Debnath, T. K., Xhemalce, B., & Miller, K. M.
- Affiliations
- Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, U.S.A.
- ORCID
- Miller, Kyle M.
- Venue
- Essays in Biochemistry
- Publisher
- Portland Press Ltd.
- Published
- 2020-08-18
- Volume
- 64
- Issue
- 5
- Pages
- 687-703
- ISSN
- 0071-1365
- 1744-1358
- Cited by
- 65
- References
- 27
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.